These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32292113)

  • 1. Stem Cell-Based Therapy for Coronavirus Disease 2019.
    Zhao RC
    Stem Cells Dev; 2020 Jun; 29(11):679-681. PubMed ID: 32292113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential.
    Khoury M; Rocco PRM; Phinney DG; Krampera M; Martin I; Viswanathan S; Nolta JA; LeBlanc K; Galipeau J; Weiss DJ
    Cytotherapy; 2020 Nov; 22(11):602-605. PubMed ID: 32933835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review].
    Shi X; Yu L; Ding C
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1979-1991. PubMed ID: 33169564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment.
    O'Driscoll L
    Drug Discov Today; 2020 Jul; 25(7):1124-1125. PubMed ID: 32387262
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell research progress for the treatment of COVID-19.
    Yao D; Ye H; Huo Z; Wu L; Wei S
    J Int Med Res; 2020 Sep; 48(9):300060520955063. PubMed ID: 32972277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
    Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
    Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
    Wang J; Zou W; Liu J
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia.
    Zhang Y; Ding J; Ren S; Wang W; Yang Y; Li S; Meng M; Wu T; Liu D; Tian S; Tian H; Chen S; Zhou C
    Stem Cell Res Ther; 2020 May; 11(1):207. PubMed ID: 32460839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
    Zayed M; Iohara K
    Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded Mesenchymal Stem Cells: a novel therapeutic approach of SARS-CoV-2 pneumonia (COVID-19). Concepts regarding a first case in Spain.
    Soler Rich R; Rius Tarruella J; Melgosa Camarero MT
    Med Clin (Barc); 2020 Oct; 155(7):318-319. PubMed ID: 32753110
    [No Abstract]   [Full Text] [Related]  

  • 12. [Guide for the prevention and treatment of coronavirus disease 2019].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):473-489. PubMed ID: 32486556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 and COVID-19: How much do we know?
    Wang M; Liao Z
    Acta Virol; 2020; 64(3):288-296. PubMed ID: 32985201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not.
    Akkoc T
    Adv Exp Med Biol; 2020; 1298():167-176. PubMed ID: 32648245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
    Shu L; Niu C; Li R; Huang T; Wang Y; Huang M; Ji N; Zheng Y; Chen X; Shi L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
    Stem Cell Res Ther; 2020 Aug; 11(1):361. PubMed ID: 32811531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
    Golchin A; Seyedjafari E; Ardeshirylajimi A
    Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
    Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
    J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19.
    Khoury M; Cuenca J; Cruz FF; Figueroa FE; Rocco PRM; Weiss DJ
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32265310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Novel Coronavirus: A Bird's Eye View.
    Habibzadeh P; Stoneman EK
    Int J Occup Environ Med; 2020 Apr; 11(2):65-71. PubMed ID: 32020915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.